Center for Metabolic Imaging and Therapeutics (CMIT), University of Maryland School of Medicine, Baltimore, MD 21201, United States of America. Department of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of Medicine, Baltimore, MD 21201, United States of America.
Phys Med Biol. 2019 Apr 26;64(9):095008. doi: 10.1088/1361-6560/ab12f7.
Transcranial MRI-guided focused ultrasound (tcMRgFUS) is increasingly used to non-invasively treat a wide variety of neurological disorders including essential tremors, Parkinson's disease, and neuropathic pain. Although this treatment is an MRI-guided procedure, the current pre-treatment screening and planning involve a CT of the head to obtain 3D skull images. These images are necessary for estimating the proportion of absorbed energy and the acoustic phase shift associated with the skull and determining the transmit energy of ultrasonic waves to create thermal lesions at a desired focal spot. Ultrashort echo time (UTE) MR sequences can capture signals from tissues such as bone which have a very short transverse relaxation time. In this manuscript, we assess the use of a UTE based sequence to image the calvarium and test the feasibility of obviating the need for CT based imaging during an MR-guided focused ultrasound therapy. We demonstrate that the segmentation of bone using UTE images leads to similar skull density ratio values as determined from CT with high correlation (r = 0.88; p < 0.0001). Furthermore, through treatment specific modeling we demonstrate that the thermal profiles and focal locations are in concordance with the actual treatment plan when using the UTE based skull intensity information suggesting the possibility of replacing the CT scans with UTE based skull imaging in all tcMRgFUS procedures, potentially eliminating unnecessary radiation exposure. Overall, the results indicate that UTE MR imaging may serve as an effective and accurate alternative to CT imaging for both screening and pre-treatment planning on patients undergoing the tcMRgFUS procedure.
经颅磁共振引导聚焦超声(tcMRgFUS)越来越多地用于非侵入性治疗多种神经疾病,包括特发性震颤、帕金森病和神经性疼痛。尽管这种治疗是一种磁共振引导的程序,但目前的治疗前筛查和规划涉及头部 CT 以获得 3D 颅骨图像。这些图像对于估计与颅骨相关的吸收能量比例和声波相位偏移以及确定超声波的传输能量以在期望的焦点处产生热损伤是必要的。超短回波时间(UTE)MR 序列可以捕获具有非常短横向弛豫时间的组织(如骨骼)的信号。在本文中,我们评估了使用 UTE 序列对颅骨成像的效果,并测试了在磁共振引导聚焦超声治疗中避免对 CT 成像的需求的可行性。我们证明了使用 UTE 图像对骨骼进行分割会导致与 CT 确定的颅骨密度比具有高度相关性(r = 0.88;p < 0.0001)。此外,通过特定于治疗的建模,我们证明了当使用基于 UTE 的颅骨强度信息时,热分布和焦点位置与实际治疗计划一致,这表明在所有 tcMRgFUS 程序中,可能可以用基于 UTE 的颅骨成像代替 CT 扫描,从而可能消除不必要的辐射暴露。总体而言,结果表明 UTE MR 成像可能成为一种有效且准确的替代 CT 成像的方法,用于筛查和治疗前规划接受 tcMRgFUS 程序的患者。